Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C22H21ClN4O4S |
| Molecular Weight | 472.945 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(Cl)=C(O)C=C4
InChI
InChIKey=SVTCWAMLLWYBEI-UHFFFAOYSA-N
InChI=1S/C22H21ClN4O4S/c1-32(29,30)9-8-24-12-16-4-7-21(31-16)14-2-5-19-17(10-14)22(26-13-25-19)27-15-3-6-20(28)18(23)11-15/h2-7,10-11,13,24,28H,8-9,12H2,1H3,(H,25,26,27)
| Molecular Formula | C22H21ClN4O4S |
| Molecular Weight | 472.945 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:02:37 GMT 2025
by
admin
on
Mon Mar 31 22:02:37 GMT 2025
|
| Record UNII |
8PL9CEZ8WK
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
71315271
Created by
admin on Mon Mar 31 22:02:37 GMT 2025 , Edited by admin on Mon Mar 31 22:02:37 GMT 2025
|
PRIMARY | |||
|
1268997-70-1
Created by
admin on Mon Mar 31 22:02:37 GMT 2025 , Edited by admin on Mon Mar 31 22:02:37 GMT 2025
|
PRIMARY | |||
|
8PL9CEZ8WK
Created by
admin on Mon Mar 31 22:02:37 GMT 2025 , Edited by admin on Mon Mar 31 22:02:37 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
METABOLIC ENZYME -> INHIBITOR |
Lapatinib is a mechanism-based inactivator of CYP3A4, most likely via the formation and further oxidation of its O-dealkylated metabolite to a quinoneimine that covalently modifies the CYP3A4 apoprotein and/or heme moiety
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE TOXIC |
Specifically, the structure of O-dealkylated lapatinib has the potential to generate a reactive quinoneimine similar to the model hepatotoxin acetaminophen. lapatinib is a mechanism-based inactivator of CYP3A4, most likely via the formation and further oxidation of its O-dealkylated metabolite to a quinoneimine that covalently modifies the CYP3A4 apoprotein and/or heme moiety.
MAJOR
|
